We just received data on a new analyst forecast for $EXPE. BTIG gave a rating of 'Buy' for $EXPE.
$EXPE Analyst Ratings
Wall Street analysts have issued reports on $EXPE in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 09/09/2025
- Benchmark issued a "Buy" rating on 08/08/2025
- B. Riley Securities issued a "Buy" rating on 08/08/2025
- B of A Securities issued a "Buy" rating on 05/09/2025
- Piper Sandler issued a "Underweight" rating on 05/09/2025
- Oppenheimer issued a "Outperform" rating on 05/09/2025
- Goldman Sachs issued a "Buy" rating on 05/09/2025
To track analyst ratings and price targets for $EXPE, check out Quiver Quantitative's $EXPE forecast page.
$EXPE Price Targets
Multiple analysts have issued price targets for $EXPE recently. We have seen 19 analysts offer price targets for $EXPE in the last 6 months, with a median target of $206.0.
Here are some recent targets:
- Jake Fuller from BTIG set a target price of $250.0 on 09/09/2025
- Ronald Josey from Citigroup set a target price of $206.0 on 08/13/2025
- Shyam Patil from Susquehanna set a target price of $200.0 on 08/11/2025
- Trevor Young from Barclays set a target price of $197.0 on 08/08/2025
- Brad Erickson from RBC Capital set a target price of $200.0 on 08/08/2025
- Thomas Champion from Piper Sandler set a target price of $190.0 on 08/08/2025
- Ken Gawrelski from Wells Fargo set a target price of $211.0 on 08/08/2025
$EXPE Insider Trading Activity
$EXPE insiders have traded $EXPE stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $EXPE stock by insiders over the last 6 months:
- ROBERT J DZIELAK (Chief Legal Officer & Sec'y) has made 0 purchases and 2 sales selling 5,964 shares for an estimated $1,210,381.
- CRAIG A JACOBSON sold 3,000 shares for an estimated $623,328
- LANCE A SOLIDAY (SVP & Chief Accounting Officer) sold 852 shares for an estimated $175,412
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EXPE Hedge Fund Activity
We have seen 484 institutional investors add shares of $EXPE stock to their portfolio, and 521 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AQR CAPITAL MANAGEMENT LLC added 1,473,386 shares (+102.0%) to their portfolio in Q2 2025, for an estimated $248,530,750
- VALUEACT HOLDINGS, L.P. removed 838,800 shares (-75.1%) from their portfolio in Q2 2025, for an estimated $141,488,784
- AMUNDI removed 786,150 shares (-61.0%) from their portfolio in Q2 2025, for an estimated $132,607,782
- LSV ASSET MANAGEMENT added 725,797 shares (+497.0%) to their portfolio in Q2 2025, for an estimated $122,427,437
- BALYASNY ASSET MANAGEMENT L.P. removed 660,934 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $111,103,005
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 639,064 shares (-38.8%) from their portfolio in Q2 2025, for an estimated $107,797,315
- CLEARBRIDGE INVESTMENTS, LLC added 572,952 shares (+127.1%) to their portfolio in Q2 2025, for an estimated $96,645,543
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
